BERLIN – The German pharmaceutical company Bayer entered into exclusive negotiations to purchase Merck's consumer drug division.
The offer, according to reports from sources close to the negotiations between the companies, would amount to about 14 billion dollars, to be paid partly in cash and partly with an exchange of pharmaceutical assets, with the probably formation of a common joint venture. Bayer remained the only one in contention after the withdrawal of the British Reckitt Benckiser.
2.05.2014 – TICINO COURIER
AstraZeneca, Pfizer raise offer to 50 pounds, but British company says no
Friday 2nd May 2014 Reuters
LONDON, May 2 (Reuters) - AstraZeneca also rejected a new takeover offer by US drugmaker Pfizer, which raised its offer to £50 ($84.47) per share. The board of the British company said no to the improvement proposal which values the group at 106 billion dollars, or 63 billion pounds, stressing that the offer does not fully value the group.
"Pfizer's proposal will dilute dramatically
